Cornercap Investment Counsel’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,615	Closed	-$740K	–	527
2024 Q2	$740K	Sell	11,615 -110	-0.9%	-$7.14K	0.12%	307
2024 Q1	$811K	Hold	11,725	–	–	0.12%	306
2023 Q4	$647K	Hold	11,725	–	–	0.11%	347
2023 Q3	$681K	Sell	11,725 -15	-0.1%	-$866	0.12%	334
2023 Q2	$632K	Buy	11,740 +559	+5%	+$24.8K	0.11%	344
2023 Q1	$444K	Buy	+11,181	New	+$471K	0.08%	427
2021 Q3	–	Sell	-36,818	Closed	-$1.29M	–	539
2021 Q2	$1.29M	Buy	+36,818	New	+$1.25M	0.14%	203
2021 Q1	–	Sell	-9,315	Closed	-$574K	–	529
2020 Q4	$574K	Buy	+9,315	New	+$267K	0.08%	375
2020 Q2	–	Sell	-6,361	Closed	-$259K	–	424
2020 Q1	$259K	Sell	6,361 -4,714	-43%	-$251K	0.05%	369
2019 Q4	$683K	Sell	11,075 -100	-0.9%	-$6.62K	0.09%	358
2019 Q3	$814K	Sell	11,175 -13,630	-55%	-$1.02M	0.12%	343
2019 Q2	$2.04M	Sell	24,805 -2,975	-11%	-$212K	0.27%	117
2019 Q1	$1.96M	Sell	27,780 -1,175	-4%	-$69.1K	0.27%	118
2018 Q4	$1.3M	Sell	28,955 -805	-3%	-$42.2K	0.2%	150
2018 Q3	$1.68M	Buy	29,760 +4,685	+19%	+$287K	0.22%	139
2018 Q2	$1.68M	Sell	25,075 -825	-3%	-$51.5K	0.24%	122
2018 Q1	$1.51M	Buy	25,900 +14,650	+130%	+$930K	0.21%	138
2017 Q4	$725K	Buy	+11,250	New	+$700K	0.1%	316